Laetus Aquired by Danaher

Change of ownership will significantly enhance Laetus' growth opportunities through increased scale and access to complementary capabilities.

Laetus, a global leader in inline quality inspection and track and trace systems, today announced it has been acquired by Danaher. Laetus will operate as an independent business within the Product Identification Platform.

Alex Lever, newly appointed Managing Director Laetus, commented, "This is an exciting next step in the development of Laetus, both for our customers and for our associates. We will strengthen our existing solution offerings through continued investment in research and development while benefitting from Danaher's established software capabilities and global presence.

Christoph Staub, General Manager for the Track and Trace business in Laetus stated, "Application of the Danaher Business System will enhance our ability to serve our customers and expand the capabilities of Laetus associates. This acquisition reaffirms the Laetus strategy and accomplishments to date; our team is excited to be joining a strong company focused on growth and innovation."

Alex Lever also said, "The addition of Laetus to the Danaher Product Identification team enhances the breadth of innovative solutions we offer to the packaging value chain." Other companies within the Product Identification Platform include Esko, Xrite, Pantone, Wolke, Videojet, Linx and FOBA.

Angelos Papadimitriou, CEO Coesia commented; "We are confident this acquisition will offer substantial opportunities for both the customers of Laetus and the employees. We look forward to continued commercial cooperation between Laetus and members of the Coesia group such as Flexlink and Hapa."

About Danaher
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world-class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. The Company's globally diverse team of 71,000 associates is united by a common culture and operating system, the Danaher Business System. In 2014, Danaher generated 19.9 billion Dollar in revenue.
For more information please visit: www.danaher.com

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.